• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

ethyl (2R)-2-methoxypropanoate and CAS no40105-20-2: A Comprehensive Overview of Its Chemical Properties, Applications, and Research Trends

ethyl (2R)-2-methoxypropanoate, with the CAS no40105-20-2 identifier, is a chiral ester compound that has garnered significant attention in the field of biomedical research. This compound, characterized by its unique stereochemistry and functional group arrangement, serves as a versatile building block for the synthesis of various biologically active molecules. Its structural features, including the methoxy group and the propanoate ester linkage, contribute to its reactivity and compatibility with diverse chemical environments. Recent studies have highlighted its potential applications in drug discovery, enzyme engineering, and biomaterials development, underscoring its importance in modern pharmaceutical science.

The ethyl (2R)-2-methoxypropanoate molecule exhibits a stereochemical configuration that is critical for its biological activity. The (2R) configuration at the central carbon atom ensures specific spatial arrangements of functional groups, which can influence interactions with biological targets such as enzymes, receptors, and cell membranes. This stereochemical specificity is a key factor in the compound's utility for targeted drug design and selective ligand development. Researchers have demonstrated that the 2-methoxy substituent enhances the compound's solubility and metabolic stability, making it a preferred candidate for oral drug formulations and prodrug strategies.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of ethyl (2R)-2-methoxypropanoate through catalytic methods and asymmetric transformations. A 2023 study published in Organic & Biomolecular Chemistry reported the use of chiral catalysts to achieve high enantioselectivity in the synthesis of this compound, which is crucial for applications requiring stereochemical precision. The study also emphasized the importance of optimizing reaction conditions to maximize yield and minimize byproduct formation, ensuring the compound's suitability for large-scale production in pharmaceutical manufacturing.

The ethyl (2R)-2-methoxypropanoate compound has been explored for its potential role in enzyme inhibition and metabolic pathway modulation. A 2024 investigation in Journal of Medicinal Chemistry demonstrated its ability to inhibit specific enzymes involved in inflammatory response regulation. This finding suggests that the compound could be developed into a therapeutic agent for chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. The study also highlighted the compound's low toxicity profile, which is a critical factor for its potential use in clinical applications.

Another significant area of research involving ethyl (2R)-2-methoxypropanoate is its application in biomaterials science. Researchers have investigated its use as a component in hydrogel formulations for drug delivery systems. A 2023 study published in Biomaterials Science showed that the compound can enhance the mechanical properties of hydrogels while maintaining controlled release of therapeutic agents. This dual functionality makes it a promising candidate for smart drug delivery systems that respond to physiological stimuli such as pH changes or temperature variations.

The ethyl (2R)-2-methoxypropanoate compound has also been studied for its potential in enzyme engineering and biocatalysis. A 2024 paper in Biotechnology and Bioengineering described the use of the compound as a substrate for engineered enzymes to produce chiral pharmaceutical intermediates. This approach leverages the compound's structural features to enable the synthesis of enantiomerically pure products, which is essential for pharmaceutical manufacturing due to the different biological activities of enantiomers.

From a synthetic perspective, the ethyl (2R)-2-methoxypropanoate compound is a valuable intermediate for the preparation of various functionalized esters and derivatives. Its reactivity towards nucleophilic attacks and its ability to undergo hydrolysis or transesterification reactions make it a versatile starting material for the synthesis of pharmaceuticals and agrochemicals. Researchers have also explored its use in green chemistry applications, where its low environmental impact and biodegradability are advantageous.

The ethyl (2R)-2-methoxypropanoate compound's utility extends to analytical chemistry and chemical sensing. Its unique spectroscopic properties, such as its UV-Vis absorption and fluorescence characteristics, have been utilized in the development of chemical sensors for detecting biomolecules and environmental pollutants. A 2023 study in Chemical Communications demonstrated the use of the compound as a fluorescent probe for monitoring metabolic processes in living cells, highlighting its potential in bioimaging and in vivo diagnostics.

Despite its promising applications, the ethyl (2R)-2-methoxypropanoate compound faces challenges related to stability and synthetic scalability. Researchers are actively working on optimizing its synthesis and storage conditions to ensure its viability for industrial applications. Additionally, further studies are needed to fully elucidate its biological mechanisms of action and to explore its potential in targeted therapies and personalized medicine.

As the field of biomedical research continues to evolve, the ethyl (2R)-2-methoxypropanoate compound is likely to play an increasingly important role in the development of innovative therapeutic agents and biomaterials. Its unique chemical properties, combined with its versatility in synthetic applications, position it as a key player in the advancement of pharmaceutical science and biotechnology. Ongoing research will undoubtedly uncover new opportunities for its use, further expanding its impact on healthcare and scientific innovation.

For researchers and industry professionals, the ethyl (2R)-2-methoxypropanoate compound represents a valuable resource for drug discovery, material science, and analytical chemistry. Its continued exploration will likely lead to breakthroughs in medical treatment, biotechnology, and environmental applications, underscoring the importance of further studies in this area.

• 41918-08-5(O-Methyl-L-lactic Acid Ethyl Ester)
• 923023-76-1(Propanoic acid, 2-methoxy-, propyl ester, (2R)-)
• 4324-39-4(Ethyl 2-Methoxypropanoate)
• 918440-94-5(1,4,7,10,13,16-Hexaoxacyclooctadecane-2,5,8,11,14,17-hexone, 3,6,9,12,15,18-hexamethyl-, (3R,6R,9R,12S,15S,18S)-rel-)
• 4055-08-7(Propanoic acid, 2-(acetyloxy)-,1-methylethyl ester)
• 14618-61-2(Propanoic acid,2,2'-oxybis-, diethyl ester, (R*,R*)- (9CI))
• 923023-78-3(Propanoic acid, 2-methoxy-, 1-methylethyl ester, (2S)-)
• 923023-77-2(Propyl (2S)-2-methoxypropanoate)
• 30379-61-4(Propanoic acid,2-(1-oxopropoxy)-)
• 2985-28-6(Propanoic acid,2-(acetyloxy)-, ethyl ester)